● Creditors' voluntary liquidation
LUNAC THERAPEUTICS LIMITED
LUNAC THERAPEUTICS LIMITED is tracked from The Gazette and Companies House public record. Creditors' voluntary liquidation proceedings were first recorded on 21 May 2026.
The timeline · incorporation → liquidation
18 Apr 2018
Incorporated
Registered as 11317849. Research.
15 Nov 2019
Board changes begin
First of the director resignations before failure.
21 Dec 2019
First accounts filed
accounts-with-accounts-type-dormant
6 Nov 2023
Charge registered
A registered charge granted to Epidarex Capital Iii UK, LP as Lender.
28 Feb 2025
Latest accounts filed
accounts-with-accounts-type-small
21 May 2026
Liquidator appointed
Creditors' voluntary liquidation.
21 May 2026
Gazette notice published
Notice 5138805 in The Gazette.
What the data was telling us
Readings from The Gazette and Companies House, in the firm's final two years.
Insolvency status● CVL
StatusCreditors' voluntary liquidation
Gazette refNotice 5138871
EditionThe Gazette
Appointed byMembers & creditors
UnderInsolvency Act 1986, s.100 & s.109
Ownership & control● PSC register
Beneficial ownerEpidarex Capital Iii Uk,Lp
ControlOwnership of shares 25 to 50%
Owner typeCorporate / legal entity
Controllers1 on record
Filing trajectory● Late filing
Incorporated18 Apr 2018
Last accounts28 Feb 2025
Confirmation stmtFiled
Account typeAccounts
Director stability● Board churn
Appointments7 since 2018
Resignations1 in final 12 mths
Active directors4
Avg tenure5.3 yrs
Director track record● Repeat insolvency
Other appointments24 other companies
Prior insolvencies4 dissolved or insolvent
DisqualificationsNone found
Charges & secured creditors● Floating charge
Charges1 registered
InstrumentA registered charge
HolderEpidarex Capital Iii UK, LP as Lender
Registered6 Nov 2023
Statusoutstanding
Practitioner appointed● Practitioner
PractitionerElizabeth Alexandra Aird-Brown
FirmThe MacDonald Partnership
RoleLiquidator
IP numberIP 10910
Appointed13 May 2026
View profile →The full forensic report
Every charge, every filing, every appointment, in one dossier.
Director histories across related entities, the full debenture instrument, creditor estimates, and the practitioner's record on comparable cases for LUNAC THERAPEUTICS LIMITED.